RecruitingNCT05851287

The Proactive Ophthalmic Examination Cohort

The Proactive Ophthalmic Examination Cohort of Older Adults


Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Enrollment

5,000 participants

Start Date

Feb 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The Proactive Ophthalmic Examination Cohort of Older Adults is a prospective cohort study recruiting community-dwelling older adults aged 65 years or older. Through comprehensive assessment of demographic profiles, medical histories, and ocular structural and functional parameters, alongside systematic collection of ophthalmic and systemic clinical data and biological specimens, we will establish a multidimensional, high-quality ocular health database encompassing demographic characteristics, socioeconomic factors, lifestyle variables, ocular disease risk factors, subjective ocular symptoms, objective examination findings, and biospecimens. The study will investigate the onset and progression patterns of ocular diseases, associated risk factors, and mechanisms of ocular aging in older populations, while simultaneously providing normal-controlled clinical and genomic data for other clinical studies on eye diseases. Furthermore, leveraging algorithmic innovation and artificial intelligence technologies, we will develop a personalized risk prediction and monitoring platform for age-related eye diseases, enhancing early screening and diagnostic capabilities and advancing precision medicine for ocular health in older adults.


Eligibility

Min Age: 65 Years

Inclusion Criteria1

  • \- Aged 65 years or older

Exclusion Criteria2

  • Unable to complete required systemic or ophthalmic examinations due to frailty, poor general health, or other physical limitations
  • Refusal to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05851287


Related Trials